These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2455721)

  • 1. Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anaesthetized rat.
    Hegde SS; Lokhandwala MF
    J Auton Pharmacol; 1988 Mar; 8(1):63-8. PubMed ID: 2455721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I; Thiry C; Pratz J; Lawson K
    Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
    Van der Niepen P; Dupont AG; Finne E; Six RO
    J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA; Lokhandwala MF
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
    Rosenkranz RP; McClelland DL
    Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
    Amenta F; Cavallotti C; Collier WL; De Michele M; Ricci A
    Mech Ageing Dev; 1990 May; 54(1):63-73. PubMed ID: 1973206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats.
    Lefèvre-Borg F; Lorrain J; Lechaire J; Thiry C; Hicks PE; Cavero I
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):444-55. PubMed ID: 2453748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
    Lefebvre RA; Guenaneche F; De Beurme FA
    Eur J Pharmacol; 1990 Aug; 185(1):69-79. PubMed ID: 1977599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.
    Takemoto F; Cohen HT; Satoh T; Katz AI
    Pflugers Arch; 1992 Jul; 421(4):302-6. PubMed ID: 1357625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F; Meller E
    Brain Res; 1989 Dec; 504(2):276-83. PubMed ID: 2574622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
    Van der Niepen P; Lefebvre RA; Dupont AG
    J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF; Watkins HO; Dlewati A
    Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.